-
Les Turner Symposium on ALS Unites Community Around Research and Patient Care
Northwestern scientists, clinicians, and members of the ALS community gathered in the Feinberg Pavilion for the 14th annual Les Turner Symposium on ALS to celebrate progress and share the latest research in hopes of better understanding and treating the disease.
-
New Huntington’s Treatment Prevents Protein Aggregation in Mice
In research published in Science Advances, scientists at Northwestern and Case Western Reserve universities have developed the first polymer-based therapeutic for Huntington’s disease, an incurable, debilitating illness that causes nerve cells to break down in the brain.
-
Scientists Develop Approach to Accurately Predict Pneumonia Outcomes
By applying a sophisticated machine-learning approach to electronic health records of patients with pneumonia, investigators at Northwestern University have uncovered five distinct clinical states in pneumonia.
-
Chronic Pain Can Be Predicted Within Three Days of an Injury
Within a few days of injury, scientists can predict which patients will develop chronic pain based on the extent of cross “talk” between two regions of the brain, and the person’s anxiety level after the injury, according to a new Northwestern study.
-
Implant Could Prevent Opioid Overdose Deaths
A team of scientists led by Northwestern Medicine investigators has created an implant capable of stopping an opioid overdose, according to findings published in Science Advances.
-
More Inpatient Beds Needed to Address Youth Mental Health Crisis
The number of pediatric inpatient psychiatric beds has not risen to meet demand amid a growing youth mental health crisis, according to a Northwestern Medicine-led study published in JAMA Pediatrics.
-
Thrombectomy Does Not Improve Outcomes for Patients with Large Strokes
Treatment with endovascular thrombectomy did not significantly improve outcomes after 90 days in patients with a large core stroke, as compared to patients who received standard stroke care alone, according to a recent clinical trial published in JAMA.
-
Delayed Antibody Treatment May Improve Efficacy of mRNA Vaccines
Investigators led by Pablo Penaloza-MacMaster, PhD, associate professor of Microbiology-Immunology, have discovered that administering an antibody treatment four days after mRNA vaccination significantly improved vaccine efficacy in mice, according to findings published in The Journal of Clinical Investigation.
-
Bonow Honored as Distinguished Scientist by American Heart Association
Robert Bonow, MD, the Max and Lilly Goldberg Distinguished Professor of Cardiology and a leading authority on valvular heart disease, has been named a 2024 Distinguished Scientist by the American Heart Association.
-
Little-Studied RNA Might be Key to Regulating Genetic Disorders Like Epilepsy, Autism
Scientists have discovered an RNA that controls how much or how little protein is produced by a gene, with implications for neurodevelopmental disorders like epilepsy and autism.
-
Study Identifies Potential Therapeutic Target for PTSD
Targeting a specific neural circuit through noninvasive neuromodulation may reduce symptoms in patients with posttraumatic stress disorder (PTSD), according to a recent study published in Nature Neuroscience.
-
Feinberg Celebrates 100 Years of The Journal of Clinical Investigation
Investigators from Feinberg School of Medicine and fellow academic and research institutions celebrated the 100-year anniversary of The Journal of Clinical Investigation during a day-long symposium in the Hughes Auditorium on October 18.
-
Youth Opioid Overdoses Spiked During Pandemic, Study Finds
Youth opioid overdoses have risen since the pandemic, according to a study analyzing nationwide EMS encounters recently published in JAMA.
-
Bridging Generational Differences at Medical Education Day
Faculty, staff, trainees and students came together to share educational research and best teaching practices during Feinberg’s 14th annual Medical Education Day on October 15.
-
Understanding How Deadly Lung Cancers Control the Local Immune System
Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune system responds to the tumor, according to a study published in the Proceedings of the National Academy of Sciences.
-
Improving the Science and Treatment of Glioblastoma
The average length of survival for glioblastoma has failed to improve since it was first identified in scientific literature nearly 100 years ago. Despite this, scientists at Feinberg remain steadfast in their commitment to improving the understanding and treatment of glioblastoma through rigorous research initiatives and clinical trials.
-
HIV Diagnosis Linked to Higher Risk of Meth Use in Gay and Bisexual Men
People assigned male at birth who belong to a sexual or gender minority group are twice as likely to use methamphetamine following an HIV diagnosis, according to a study published in the Proceedings of the National Academy of Sciences.
-
Medical Student Honored by Pisacano Leadership Foundation
Stephen Freeman, a fourth-year MD/MPH student at Feinberg, has been selected to participate in the Pisacano Scholars Leadership Program, a highly competitive professional development and scholarship opportunity given to exceptional future leaders in family medicine.
-
Novel Blood Test Predicts Risk of Severe Lung Disease
Northwestern Medicine investigators have created a novel blood test that identifies adults who may be at increased risk of developing severe respiratory illnesses, according to a recent study published in the American Journal of Respiratory and Critical Care Medicine.
-
Diversity and Inclusion Fall Lyceum Explores Causes of Health Inequity and Possible Solutions
Feinberg students, faculty, trainees and staff gathered in a packed Hughes Auditorium for the Office of Diversity and Inclusion’s annual Fall Lyceum on October 8.
